Back to Results
First PageMeta Content
Pharmacology / Monoclonal antibodies / Immune system / Immunology / Ulcerative colitis / TNF inhibitor / Mucositis / Inflammatory bowel disease / Biologic / Medicine / Health / Autoimmune diseases


Avaxia CEO Barbara Fox is Named an EY Entrepreneur Of The Year™ 2014 Award Finalist in New England
Add to Reading List

Document Date: 2014-05-22 11:31:36

Open Document

File Size: 259,34 KB

Share Result on Facebook

City

LEXINGTON / /

Company

Avaxia Biologics Inc. / /

Currency

USD / /

/

Event

Funding / Employment Change / FDA Phase / /

IndustryTerm

biopharmaceutical / /

MedicalCondition

serious diseases / celiac disease / inflammatory bowel disease / GI acute radiation syndrome / opportunistic infections / oral mucositis / diabetes / ulcerative colitis / active ulcerative colitis / allergic reactions / gastrointestinal disorders / /

MedicalTreatment

radiation / /

Person

Barbara Fox / Charles Liles / Cory Tromblee / Barbara S. Fox / Michael D. Rivard / /

/

Position

CEO / leader / Chief Executive Officer / EY Entrepreneur / VP Corporate Development / renowned scientific advisors / The Year™ EY Entrepreneur / Entrepreneur / /

Product

AVX-470 / /

ProvinceOrState

Massachusetts / /

Region

New England / /

Technology

pharmacokinetics / radiation / /

URL

www.avaxiabiologics.com / /

SocialTag